AU2016244121B2 - High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate - Google Patents

High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate Download PDF

Info

Publication number
AU2016244121B2
AU2016244121B2 AU2016244121A AU2016244121A AU2016244121B2 AU 2016244121 B2 AU2016244121 B2 AU 2016244121B2 AU 2016244121 A AU2016244121 A AU 2016244121A AU 2016244121 A AU2016244121 A AU 2016244121A AU 2016244121 B2 AU2016244121 B2 AU 2016244121B2
Authority
AU
Australia
Prior art keywords
oxalate
enzyme
composition
enzymes
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016244121A
Other languages
English (en)
Other versions
AU2016244121A1 (en
Inventor
Aaron B. Cowley
Helena COWLEY
Qingshan Li
Qin Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orenzymes LLC
Original Assignee
Orenzymes LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orenzymes LLC filed Critical Orenzymes LLC
Publication of AU2016244121A1 publication Critical patent/AU2016244121A1/en
Application granted granted Critical
Publication of AU2016244121B2 publication Critical patent/AU2016244121B2/en
Priority to AU2021200688A priority Critical patent/AU2021200688B2/en
Assigned to OXIDIEN PHARMACEUTICALS, LLC reassignment OXIDIEN PHARMACEUTICALS, LLC Request for Assignment Assignors: CAPTOZYME, LLC
Assigned to ORENZYMES LLC reassignment ORENZYMES LLC Request for Assignment Assignors: OXIDIEN PHARMACEUTICALS, LLC
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01002—Oxalate decarboxylase (4.1.1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01008—Oxalyl-CoA decarboxylase (4.1.1.8)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
    • C12Y102/03004—Oxalate oxidase (1.2.3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2016244121A 2015-04-02 2016-04-04 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate Active AU2016244121B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021200688A AU2021200688B2 (en) 2015-04-02 2021-02-03 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562141976P 2015-04-02 2015-04-02
US62/141,976 2015-04-02
PCT/US2016/025937 WO2016161455A2 (en) 2015-04-02 2016-04-04 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021200688A Division AU2021200688B2 (en) 2015-04-02 2021-02-03 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate

Publications (2)

Publication Number Publication Date
AU2016244121A1 AU2016244121A1 (en) 2017-11-23
AU2016244121B2 true AU2016244121B2 (en) 2020-11-05

Family

ID=57007703

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2016244121A Active AU2016244121B2 (en) 2015-04-02 2016-04-04 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
AU2021200688A Active AU2021200688B2 (en) 2015-04-02 2021-02-03 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2021200688A Active AU2021200688B2 (en) 2015-04-02 2021-02-03 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate

Country Status (7)

Country Link
US (2) US11603524B2 (en:Method)
EP (1) EP3277099B9 (en:Method)
KR (1) KR20180044225A (en:Method)
CN (1) CN107960105B (en:Method)
AU (2) AU2016244121B2 (en:Method)
CA (1) CA2984763C (en:Method)
WO (1) WO2016161455A2 (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107868776A (zh) * 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
CN108588060B (zh) * 2017-03-07 2020-12-01 武汉康复得生物科技股份有限公司 一种用丝状真菌宿主细胞表达的重组草酸脱羧酶
CN108977455B (zh) * 2018-08-01 2021-07-20 武汉康复得生物科技股份有限公司 用于生产草酸脱羧酶的重组质粒、大肠杆菌表达系统及方法和应用
CN108998462B (zh) * 2018-08-01 2021-06-18 武汉康复得生物科技股份有限公司 含锰离子重组蛋白的大肠杆菌表达系统及其应用方法
CN113447585B (zh) * 2021-06-28 2022-03-15 中国食品药品检定研究院 基于液相色谱评价体外辅助生殖用液质量的方法
WO2023091607A1 (en) * 2021-11-19 2023-05-25 The Better For You Company, Llc Oxalic acid or oxalate free inonotus obliquus extract and uses thereof
WO2023154879A2 (en) * 2022-02-11 2023-08-17 Codexis, Inc. Engineered oxalate decarboxylases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130108607A1 (en) * 2009-11-25 2013-05-02 Aaron Cowley Methods and Compositions for Treating Oxalate-Related Conditions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455371A (en) 1982-03-03 1984-06-19 The Ohio State University Research Foundation Oxalate oxidase composition for assay of oxalate
US5137722A (en) 1991-01-16 1992-08-11 Allegheny-Singer Research Institute Extract and pharmaceutical composition for treatment of calcium oxalate stone disease
AU656761B2 (en) 1991-02-25 1995-02-16 Syngenta Limited Newly characterised oxalate oxidase and uses therefor
UA34467C2 (uk) 1992-11-30 2001-03-15 Зенека Лімітед Виділений та очищений днк фрагмент, що кодує оксалат-декарбоксилазу
US6187571B1 (en) 1992-12-07 2001-02-13 Biogemma Use of a DNA sequence coding for a protein capable of degrading oxalic acid as selection gene
US5945273A (en) 1997-06-03 1999-08-31 Human Genome Sciences, Inc. Human oxalyl-coa decarboxylase
US5635616A (en) 1995-06-02 1997-06-03 Human Genome Sciences, Inc. Human oxalyl-CoA decarboxylase
US5604111A (en) 1994-06-20 1997-02-18 University Of Florida Research Foundation Method and kit for detection of oxalate
US6214980B1 (en) 1994-06-20 2001-04-10 University Of Florida Materials and methods for detection of Oxalobacte formigenes
US6090628A (en) 1994-06-20 2000-07-18 University Of Florida Materials and methods for detection of Oxalobactor formigenes
US5776701A (en) 1996-05-31 1998-07-07 University Of Florida Materials and methods for detecting oxalate
US6297425B1 (en) 1997-03-21 2001-10-02 Pioneer Hi-Bred International, Inc. Gene encoding oxalate decarboxylase from aspergillus phoenices
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
DE69841200D1 (de) 1997-05-23 2009-11-12 Oxthera Inc Oxalate-abbauende mikroorganismen oder oxalate-abbauende enzyme zur verhütung der oxalate-verwandten krankheiten
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6521645B2 (en) 2000-11-20 2003-02-18 The University Of Kansas Medical Center Methods for the treatment and prevention of urinary stone disease
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US6929940B1 (en) 2002-08-20 2005-08-16 University Of Florida Research Foundation, Inc. Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
WO2004018634A2 (en) 2002-08-20 2004-03-04 University Of Florida Polynucleotide encoding oxalate decarboxylase from aspergillus niger and methods of use
US20080311101A1 (en) * 2005-06-10 2008-12-18 Shenoy Bhami C Method to Reduce Oxalate Concentration by Administration of Oxalate Oxidase Crystals
KR20080035685A (ko) 2005-08-19 2008-04-23 나노시스, 인크. 전자 등급의 금속 나노구조체
CA2645871A1 (en) 2005-12-14 2007-06-21 Oxthera Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OXALATE-ASSOCIATED DISEASE
JP5558002B2 (ja) * 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
RU2009107184A (ru) 2006-08-02 2010-09-10 Элтус Фармасьютикалз Инк. (Us) Кристаллизованная оксалатдекарбоксилаза и способы применения
WO2009087826A1 (ja) * 2008-01-04 2009-07-16 Amano Enzyme Inc. シュウ酸脱炭酸酵素の生産に利用される組換え発現プラスミドベクター及び組換え菌、並びに組換えシュウ酸脱炭酸酵素の生産方法
US8431122B2 (en) * 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
CN102492683B (zh) * 2011-12-01 2013-06-12 南宁奕德环境科技有限公司 一种交联草酸脱羧酶聚集体的制备方法
US9520794B2 (en) 2012-07-25 2016-12-13 Philips Lighting Holding B.V Acceleration of output energy provision for a load during start-up of a switching power converter
JP6574414B2 (ja) * 2013-06-07 2019-09-11 アレナ ファーマシューティカルズ， インコーポレイテッド 透析のための組成物、方法、および器具
CN104606100A (zh) 2015-01-12 2015-05-13 德利宝(广州)香料有限公司 一种含洋甘菊复配杭白菊提取物香精的牙膏及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130108607A1 (en) * 2009-11-25 2013-05-02 Aaron Cowley Methods and Compositions for Treating Oxalate-Related Conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOTTEY, S. et al "Protein-folding location can regulate manganese binding versus copper- or zinc-binding" Nature, 2008, Volume 455 pages 1138-1142 *

Also Published As

Publication number Publication date
AU2021200688A1 (en) 2021-03-04
US20180362955A1 (en) 2018-12-20
CA2984763C (en) 2023-08-08
AU2021200688B2 (en) 2023-04-20
EP3277099A4 (en) 2018-10-24
EP3277099B1 (en) 2023-11-08
EP3277099A2 (en) 2018-02-07
CA2984763A1 (en) 2016-10-06
US20220298497A1 (en) 2022-09-22
CN107960105A (zh) 2018-04-24
AU2016244121A1 (en) 2017-11-23
CN107960105B (zh) 2025-05-16
EP3277099B9 (en) 2024-05-29
WO2016161455A2 (en) 2016-10-06
KR20180044225A (ko) 2018-05-02
WO2016161455A3 (en) 2016-11-24
US11603524B2 (en) 2023-03-14

Similar Documents

Publication Publication Date Title
AU2021200688B2 (en) High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
EP1976553B1 (en) Compositions and methods for oxalate reduction
JP5997610B2 (ja) シュウ酸塩に関連した症状を治療する方法及び組成物
US20010016220A1 (en) Encapsulated multifunctional biologically active food component, process for its production and its use
KR20160055721A (ko) 장용 투여에 적합한 영양소 및 소화 효소를 함유하는 조성물
JP2017500885A (ja) 高力価パンクレアチン医薬組成物
DK2449098T3 (en) PURIFICATION AND INSULATION OF RECOMBINANT OXALATE DEGRADING ENZYMES AND SPRAY DRIED PARTICLES CONTAINING OXALATE DEGRADING ENZYMER
Ma et al. Allergenicity, assembly and applications of ovalbumin in egg white: a review
AU2007302899A1 (en) Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization
JPWO2018181066A1 (ja) 新規ビフィドバクテリウム属細菌
CN114561333B (zh) 一种转化支链氨基酸的工程菌及在制备治疗枫糖尿症产品中的应用
US9144602B2 (en) Treatment of fructose malabsorption
JP2012140396A (ja) コレステロール低下用組成物
CN120400287A (zh) 一种提升乙醇脱氢酶激活活性的鸡肉酶解物及其制备方法与应用
CN113755549A (zh) 一种壁虎酶解物及其制备方法和抗肿瘤应用

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: OXIDIEN PHARMACEUTICALS, LLC

Free format text: FORMER OWNER(S): CAPTOZYME, LLC

PC Assignment registered

Owner name: ORENZYMES LLC

Free format text: FORMER OWNER(S): OXIDIEN PHARMACEUTICALS, LLC